We have placed cookies on your computer to help make this website better. We use a Matomo Analytics script which sets performance cookies. More details and information can be found in our cookie policy. Please refer to the privacy statement to adjust your settings for the website analytics tracking by Matomo (e.g. deny use/opt-out).

The Grünenthal Group is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout and inflammation. We are a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 29 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 155 countries and we employ around 4,700 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

Beyond our overarching purpose – to improve the health of people around the globe – we want to create shared value through sustainability for our company and society as a whole.

... Responsibility

In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

Innovation is at the heart of everything that we do. It’s the driving force behind new ideas and future therapies.

... Research & Development

For us, innovation goes beyond drug development. Our innovation is built on expert knowledge of disease-pathophysiology’s, understanding of the patient, the use of big data and state-of-the-art technologies such as devices that result in innovative solutions for the patients need.

... Strategy

Our R&D pipeline is a source of great excitement – we currently have several new drug candidates and technologies in different phases of development.

... Pipeline

Our key innovation area is pain.

... Focus area

Collaboration with the scientific community is central to our R&D strategy. Let’s work together – collaborate with us!

... Collaborate with us

We believe that success comes from close collaborations founded on a shared vision to develop innovative medicines for patients that suffer from diseases with high unmet needs.

... Partnering

We strengthen and develop our core markets Europe, North America, Latin America and Asia through acquisitions, asset deals, in-licensing, commercialization and distribution deals.

... Areas of interest

We work with the world’s biggest public-private partnership organisation in the life sciences as co-leaders of the latest pain initiative.

... Public Private Partnerships

Let’s work together

Collaboration with the scientific community is central to our R&D strategy. Through partnerships, we can challenge our approach, complement our own expertise with external knowledge, and deliver improved outcomes.

Who are we looking to partner with?

We are constantly looking for individuals and companies to collaborate with on promising new research and development projects. We’re open to working with partners including scientific experts, academic institutions, biotechs, and CROs.

... Find out more

What types of partnerships?

We are interested in partnership opportunities that include co-development, in-licensing, partnering and outsourcing of activities at all stages of the R&D process.

To ensure the best possible outcomes from our partnering activities, we carry out due-diligence to make sure we find the right fit – on both sides. We also tailor our partnerships and the selection of our partners to address specific scientific questions such as drug discovery to clinical studies

Our guiding principles

We have extensive experience in fostering successful collaborations with a diverse range of organisations around the world.

Our success is based on the following guiding principles:

entrepreneurial spirit – we believe that the freedom to think and act innovatively will result in solutions that deliver the best possible outcomes for patients
transparency at all stages of the R&D process – we understand that openness and the exchange of ideas between teams leads to the development of innovative solutions
long-term view and planning security – our specific company structure ensures that we have a long-term, sustainable focus
strong commitment to deliver on our promises – our mission is to improve the lives of patients through innovation and we are dedicated to that purpose